SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001956
Filing Date
2020-03-03
Accepted
2020-03-03 16:02:40
Documents
106
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vvus-20191231x10k.htm 10-K 3838610
2 EX-4.2 vvus-20191231ex421f83c4c.htm EX-4.2 61611
3 EX-21.1 vvus-20191231ex211a001f7.htm EX-21.1 2432
4 EX-23.1 vvus-20191231ex231e2bd54.htm EX-23.1 2824
5 EX-31.1 vvus-20191231ex311cc757e.htm EX-31.1 14774
6 EX-31.2 vvus-20191231ex3121c20aa.htm EX-31.2 15025
7 EX-32.1 vvus-20191231ex321e643e9.htm EX-32.1 13877
8 GRAPHIC vvus20191231x10k001.jpg GRAPHIC 65688
  Complete submission text file 0001558370-20-001956.txt   14052343

Data Files

Seq Description Document Type Size
9 EX-101.INS vvus-20191231.xml EX-101.INS 3145964
10 EX-101.SCH vvus-20191231.xsd EX-101.SCH 73376
11 EX-101.CAL vvus-20191231_cal.xml EX-101.CAL 96274
12 EX-101.DEF vvus-20191231_def.xml EX-101.DEF 343331
13 EX-101.LAB vvus-20191231_lab.xml EX-101.LAB 747611
14 EX-101.PRE vvus-20191231_pre.xml EX-101.PRE 612193
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33389 | Film No.: 20682103
SIC: 2834 Pharmaceutical Preparations